Skip to main content
Watch Insiders

Corporate insider profile

Christopher R. Cline Insider Trades

Latest reported as CHIEF FINANCIAL OFFICER of Travere Therapeutics, Inc. (TVTX).

Purchase filings
0
Reported companies
1
Net open-market value
-$3,655,493.91
Latest transaction
Sep 15, 2026

Affiliated corporations

Reported company relationships

TVTXLatest reported

Travere Therapeutics, Inc.

CHIEF FINANCIAL OFFICER

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)CHIEF FINANCIAL OFFICERSale50,508$62.34$3,148,542
Sep 2, 2026Travere Therapeutics, Inc. (TVTX)CHIEF FINANCIAL OFFICERSale642$66.37$42,610
May 6, 2026Travere Therapeutics, Inc. (TVTX)CHIEF FINANCIAL OFFICERSale2,491$46.31$115,368
Apr 15, 2026Travere Therapeutics, Inc. (TVTX)CHIEF FINANCIAL OFFICERSale8,327$41.91$348,974